© Newsfile
24.05.2024
COPN
LISTED
SIX
Cosmo Pharmaceuticals' Shareholders Approve All Agenda Items at Annual General Meeting
News Preview
Dublin, Ireland--(Newsfile Corp. - May 24, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced that its shareholders approved all agenda items at today's annual general meeting of shareholders. A total of 7,417,916 ordinary shares in the share capital of Cosmo were represented at this...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.05.2024
RXRX
LISTED
NASDAQ
Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
News Preview
Dr. Hershberg is a current board member with over 25 years of experience as a physician, scientist, and entrepreneur Dr. Hershberg is a current board member with over 25 years of experience as a physician, scientist, and entrepreneur...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.05.2024
SOBI
LISTED
STO
Sobi to present new myelofibrosis data at the ASCO 2024 Annual Meeting
News Preview
Sobi will present three abstracts that highlights data from its myelofibrosis treatment option at ASCO....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
24.05.2024
SOBI
LISTED
STO
Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome
News Preview
FDA has granted Fast Track designation to emapalumab-lzsg for the potential first therapeutic option in patients with MAS...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
24.05.2024
CHEMM
LISTED
CPH
Appointment of new CFO
News Preview
ANNOUNCEMENT NO. 269...
Themefolio
Profiler
Peergroup
© EQS Newswire
24.05.2024
EUZ
LISTED
XETR
Eckert & Ziegler erhält „Best Managed Companies Award”
News Preview
Berlin, 24.05.2024. Die Eckert & Ziegler SE (ISIN DE0005659700) wurde am 23. Mai 2024 im Rahmen einer Preisverleihung in Frankfurt am Main mit dem „Best Managed Companies Award“ ausgezeichnet. Mit diesem Preis würdigen Deloitte Private, UBS, die Frankfurter Allgemeine Zeitung und der Bundesverband der Deutschen Industrie e.V. hervorragend gefüh......
Themefolio
Profiler
Peergroup
© EQS Newswire
24.05.2024
EUZ
LISTED
XETR
Eckert & Ziegler receives “Best Managed Companies Award”
News Preview
Berlin, 24 May 2024. Eckert & Ziegler SE (ISIN DE0005659700) was honored with the “Best Managed Companies Award” at an award ceremony in Frankfurt am Main on May 23, 2024. With this award, Deloitte Private, UBS, Frankfurter Allgemeine Zeitung and the Federation of German Industries (Bundesverband der Deutschen Industrie e.V.) recognize outstand......
Themefolio
Profiler
Peergroup
© Globe Newswire
23.05.2024
ZEAL
LISTED
CPH
Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agonist dapiglutide
News Preview
Company announcement – No. 27 / 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.05.2024
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. to Present at the Jefferies Global Healthcare Conference
News Preview
MINNEAPOLIS, May 23, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies Global Healt...
Themefolio
Profiler
Peergroup
© EQS Newswire
23.05.2024
GXI
LISTED
XETR
Gerresheimer übernimmt Blitz LuxCo Sarl, die Holding Gesellschaft der Bormioli Pharma Gruppe – Moulded Glass Geschäft wird strategisch neu aufgesetzt
News Preview
Gerresheimer übernimmt Blitz LuxCo Sarl, die Holding Gesellschaft der Bormioli Pharma Gruppe – Moulded Glass Geschäft wird strategisch neu aufgesetzt
Strategische Akquisition: Komplementäres Produktportfolio und breite Abdeckung mit Produktionsstandorten in Europa
Gerresheimer untermauert führende Marktposition als Komplettanbieter für die Pharma......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.05.2024
GXI
LISTED
XETR
Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business
News Preview
Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business
Strategic acquisition: Complementary product portfolio and broad footprint with production sites in Europe
Gerresheimer underpins leading market position as a full-service provider for the pharmaceutical and biote......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.05.2024
GXI
LISTED
XETR
Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business
News Preview
Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business
Strategic acquisition: Complementary product portfolio and broad footprint with production sites in Europe
Gerresheimer underpins leading market position as a full-service provider for the pharmaceutical and biote......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
23.05.2024
GXI
LISTED
XETR
Gerresheimer übernimmt Blitz LuxCo Sarl, die Holding Gesellschaft der Bormioli Pharma Gruppe / Geschäftsbereich Moulded Glass wird strategisch neu bewertet
News Preview
Gerresheimer übernimmt Blitz LuxCo Sarl, die Holding Gesellschaft der Bormioli Pharma Gruppe – Geschäftsbereich Moulded Glass wird strategisch neu bewertet
Düsseldorf, 23. Mai 2024. Die Gerresheimer Glas GmbH, eine mittelbare Tochtergesellschaft der Gerresheimer AG, hat heute einen Kaufvertrag mit von Triton beratenen Fonds ("Triton") über den......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.05.2024
GXI
LISTED
XETR
Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group / Moulded Glass business to be strategically reviewed
News Preview
Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Moulded Glass business to be strategically reviewed
Düsseldorf, May 23, 2024. Gerresheimer Glas GmbH, an indirect subsidiary of Gerresheimer AG, has today signed a purchase agreement with funds advised by Triton ("Triton") for the acquisition of Blitz L......
Themefolio
Profiler
Peergroup
© Globe Newswire
23.05.2024
IBAB
LISTED
EURONEXT
IBA Business Update – First Quarter 2024
News Preview
Louvain-la-Neuve, Belgium, 23 May 2024 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its business update for the first quarter ending 31 March 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
23.05.2024
EAPI
LISTED
EURONEXT
EUROAPI strengthens its presence in animal health with a €130-150 million supply contract
News Preview
Paris – May 23, 2024 – EUROAPI announces today that it has entered into a Contract Manufacturing Organization (CMO) agreement with a global animal health company. As part of this collaboration, EUROAPI will supply its client with a key veterinary product. The total contract value is expected to range between €130 and 150 million, over the 2025-2029...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.05.2024
GNFT
LISTED
EURONEXT
GENFIT: May 22, 2024 Combined Shareholders Meeting Results
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 22, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the results of the Combined Shareholders Meeting which took place on May...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.05.2024
BAVA
LISTED
CPH
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
News Preview
COPENHAGEN, Denmark, May 22, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 187,020 as a consequence of employees’ exercise of warrants....
Themefolio
Profiler
Peergroup
© EQS Newswire
22.05.2024
EVT
LISTED
XETR
Evotec reports Q1 2024 results and provides corporate update
News Preview
CHALLENGING Q1 WITH SOFTNESS MAINLY IN TRANSACTIONAL/DEVELOPMENT SHARED R&D BUSINESS AGAINST A STRONG COMPARABLE QUARTER
STRONG START WITH JUST – EVOTEC BIOLOGICS IN Q1 2024
POSITIVE MOMENTUM IN SHARED R&D DISCOVERY CLOSED SALES POINT TO RECOVERY OF REVENUES TOWARDS END OF THE YEAR
RESET FOR PROFITABLE GROWTH INITIATED, NEW REPORTING SEG......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.05.2024
EVT
LISTED
XETR
Ergebnisse für das erste Quartal 2024 und Update zur Unternehmensentwicklung
News Preview
HERAUSFORDERNDES Q1 2024 MIT SCHWÄCHEN DES TRANSAKTIONALEN-/ DEVELOPMENT-GESCHÄFTS IN SHARED R&D GEGENÜBER EINEM STARKEN VERGLEICHSQUARTAL
STARKER START VON JUST – EVOTEC BIOLOGICS IN Q1 2024
POSITIVE DYNAMIK IM AUFTRAGSBESTAND VON SHARED R&D DISCOVERY DEUTET AUF ERHOLUNG DES UMSATZES ZUM JAHRESENDE HIN
NEUAUSRICHTUNG AUF PROFITABLES WAC......
Themefolio
Profiler
Peergroup
© Globe Newswire
21.05.2024
BAVA
LISTED
CPH
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program
News Preview
COPENHAGEN, Denmark, May 21, 2024 – Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced and initiated on May 8, 2024, has now been terminated, as the intended number of shares under the program has been repurchased. The program was executed in accordance with the provisions of Regulation (EU) No. 596/2014...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.05.2024
GMAB
LISTED
CPH
Genmab Completes Acquisition of ProfoundBio
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.05.2024
GMAB
LISTED
CPH
Transactions in Connection with Share Buy-back Program
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.05.2024
RAY B
LISTED
STO
Raytech Holding: Making Nasdaq Debut as It Pioneers Personal Care Electrical Appliances in a Booming Market
News Preview
Hong Kong, May 20, 2024 (GLOBE NEWSWIRE) -- In the dynamic world of personal grooming, Raytech Holding (Nasdaq: RAY) emerges as a shining star, dedicated to enhancing consumer lifestyles through its innovative range of personal care electrical appliances. Since its inception in 2013, this Hong Kong-based company has garnered over 10 years of...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.05.2024
DBV
LISTED
EURONEXT
DBV Technologies Announces Plan to Implement ADS Ratio Change
News Preview
Châtillon, France, May 17, 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.05.2024
AUTL
LISTED
NASDAQ
Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
News Preview
Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.05.2024
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B in the attach...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.05.2024
CHEMM
LISTED
CPH
Notification of managers’ transactions
News Preview
ANNOUNCEMENT NO. 268...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.05.2024
KDEV
LISTED
STO
Karolinska Development’s Annual General Meeting 2024
News Preview
STOCKHOLM, SWEDEN – May 16, 2024. Karolinska Development AB (publ) (“Karolinska Development” or the “Company”) held the Annual General Meeting on May 16, 2024. The shareholders have had the right to exercise their voting rights in advance through postal voting pursuant to item 13 in the articles of association. Therefore, shareholders have had the...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.05.2024
TRAW
LISTED
NASDAQ
Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update
News Preview
Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update...
Themefolio
Profiler
Peergroup
© EQS Newswire
16.05.2024
SRT
LISTED
XETRA
Sartorius to advance drug discovery and manufacturing with AI in collaboration with NVIDIA
News Preview
Göttingen, Germany, May 16, 2024
Sartorius to advance drug discovery and manufacturing with AI in collaboration with NVIDIA
Exploring advanced technologies to help bring novel therapies to patients faster
Sartorius to leverage NVIDIA solutions used in live-cell imaging platforms in drug discovery, and predictive design of manufacturing processe......
Themefolio
Profiler
Peergroup
© Globe Newswire
16.05.2024
COLO B
LISTED
CPH
Coloplast A/S - Invitation to Coloplast's Meet the Management event on 6 June 2024 (gentle reminder)
News Preview
The event will take place on Thursday, 6 June 2024 at Coloplast’s HeadquartersHoltedam 3, 3050 Humlebaek, Denmarkfrom 11.30 - 18.00 CEST (Central European Summer Time)...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.05.2024
ZEAL
LISTED
CPH
Zealand Pharma Announces Financial Results for the First Quarter of 2024
News Preview
Company announcement - No. 26 / 2024...
Themefolio
Profiler
Peergroup
© PR Newswire
15.05.2024
ATNM
LISTED
XASE
Actinium to Host KOL Webinar to Discuss Iomab-ACT Commercial CAR T-Cell Therapy Trial Design, Objectives and Potential Market Opportunity
News Preview
- KOL and principal investigator, Dr. Farrukh Awan, Professor of Medicine, Division of Hematology Oncology at University of Texas Southwestern to join Actinium management on the webinar
- Webinar to be held on Monday, May 20th at 8:00 AM ET
NEW YORK, May 15, 2024 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or...
Themefolio
Profiler
Peergroup
© EQS Newswire
15.05.2024
EVT
LISTED
XETR
Evotec SE to announce results for first quarter 2024 on 22 may 2024
News Preview
Hamburg, Germany, 15 May 2024:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for the first quarter of 2024 on Wednesday, 22 May 2024.
The Company is going to hold a conference call to discuss the results as well as provide an update on its performance. The conference call......
Themefolio
Profiler
Peergroup
© EQS Newswire
15.05.2024
EVT
LISTED
XETR
Bekanntgabe der Ergebnisse für das erste Quartal 2024 am 22. Mai 2024
News Preview
Hamburg, 15. Mai 2024:
Die Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) veröffentlicht am Mittwoch, 22. Mai 2024, ihren Bericht über das erste Quartal 2024.
In einer Telefonkonferenz in englischer Sprache werden die Ergebnisse und Schwerpunkte aus dem Berichtszeitraum näher erläutert. Außerdem wird über......
Themefolio
Profiler
Peergroup
© EQS Newswire
15.05.2024
EVT
LISTED
XETR
Bekanntgabe der Ergebnisse für das erste Quartal 2024 am 22. Mai 2024
News Preview
Hamburg, 15. Mai 2024:
Die Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) veröffentlicht am Mittwoch, 22. Mai 2024, ihren Bericht über das erste Quartal 2024.
In einer Telefonkonferenz in englischer Sprache werden die Ergebnisse und Schwerpunkte aus dem Berichtszeitraum näher erläutert. Außerdem wird über......
Themefolio
Profiler
Peergroup
© Globe Newswire
15.05.2024
POAI
LISTED
NASDAQ
Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update
News Preview
Company to host investor call and webcast today, May 15th, at 8:30am EDT Company to host investor call and webcast today, May 15th, at 8:30am EDT...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.05.2024
ATAI
LISTED
NASDAQ
atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates
News Preview
NEW YORK and BERLIN, May 15, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced first quarter 2024 financial results, provided corporate updates and announced a transition in its leadership....
Themefolio
Profiler
Peergroup
© Globe Newswire
15.05.2024
CHEMM
LISTED
CPH
Major shareholder announcement – BlackRock, Inc.
News Preview
ANNOUNCEMENT NO. 266...
Themefolio
Profiler
Peergroup
© EQS Newswire
15.05.2024
FYB
LISTED
XETR
MS Pharma wird Kommerzialisierungspartner für FYB203, Formycons Eylea® Biosimilar-Kandidat (Aflibercept), in der MENA-Region
News Preview
Pressemitteilung // 15. Mai 2024
MS Pharma wird Kommerzialisierungspartner für FYB203, Formycons Eylea® Biosimilar-Kandidat (Aflibercept), in der MENA-Region
Planegg-Martinsried – Klinge Biopharma GmbH („Klinge"), Lizenznehmer und exklusiver Inhaber der weltweiten Vermarktungsrechte für FYB203, Formycons Biosimilar-Kandidat zu Eylea®1 (Aflibe......
Themefolio
Profiler
Peergroup
© EQS Newswire
15.05.2024
FYB
LISTED
XETR
MS Pharma wird Kommerzialisierungspartner für FYB203, Formycons Eylea® Biosimilar-Kandidat (Aflibercept), in der MENA-Region
News Preview
Pressemitteilung // 15. Mai 2024
MS Pharma wird Kommerzialisierungspartner für FYB203, Formycons Eylea® Biosimilar-Kandidat (Aflibercept), in der MENA-Region
Planegg-Martinsried – Klinge Biopharma GmbH („Klinge"), Lizenznehmer und exklusiver Inhaber der weltweiten Vermarktungsrechte für FYB203, Formycons Biosimilar-Kandidat zu Eylea®1 (Aflibe......
Themefolio
Profiler
Peergroup
© EQS Newswire
15.05.2024
FYB
LISTED
XETR
MS Pharma becomes Partner for the Commercialization of FYB203, Formycon’s Biosimilar Candidate to Eylea® (Aflibercept), in the MENA Region
News Preview
Presse Release // May 15, 2024
MS Pharma becomes Partner for the Commercialization of FYB203, Formycon’s Biosimilar Candidate to Eylea® (Aflibercept), in the MENA Region
Planegg-Martinsried – Klinge Biopharma GmbH ("Klinge"), licensee and exclusive holder of the worldwide commercialization rights for FYB203, Formycon's biosimilar candidate to......
Themefolio
Profiler
Peergroup
© EQS Newswire
15.05.2024
FYB
LISTED
XETR
MS Pharma becomes Partner for the Commercialization of FYB203, Formycon’s Biosimilar Candidate to Eylea® (Aflibercept), in the MENA Region
News Preview
Presse Release // May 15, 2024
MS Pharma becomes Partner for the Commercialization of FYB203, Formycon’s Biosimilar Candidate to Eylea® (Aflibercept), in the MENA Region
Planegg-Martinsried – Klinge Biopharma GmbH ("Klinge"), licensee and exclusive holder of the worldwide commercialization rights for FYB203, Formycon's biosimilar candidate to......
Themefolio
Profiler
Peergroup
© PR Newswire
15.05.2024
ATNM
LISTED
XASE
Actinium Announces Oral Presentation Detailing Improved Survival Outcomes in TP53 Positive Patients at the EHA 2024 Annual Congress and Presentation of Long-Term Efficacy Results in Older Patients Receiving an Iomab-B Led Bone Marrow Transplant in the Pha
News Preview
- Median Overall Survival of 5.49 months observed in patients with a TP53 mutation receiving an Iomab-B led allogeneic bone marrow transplant compared to 1.66 months in patients that did not receive Iomab-B (hazard ratio=0.23, p=0.0002) in the Phase 3 SIERRA Trial
- Long-term efficacy results in older patients with active relapsed or refractory a...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.05.2024
ASND
LISTED
NASDAQ
Ascendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon™ PTH for Adults with Hypoparathyroidism
News Preview
- Prescription Drug User Fee Act (PDUFA) goal date extended by three months for further review of submission to August 14, 2024...
Themefolio
Profiler
Peergroup
© EQS Newswire
14.05.2024
1SXP
LISTED
XETR
SCHOTT Pharma bestätigt Prognose für das Geschäftsjahr 2024 anlässlich seiner Q2-Ergebnisse; Geschäftsjahr 2025 durch geringeres Wachstum bei Spritzen beeinflusst
News Preview
SCHOTT Pharma bestätigt Prognose für das Geschäftsjahr 2024 anlässlich seiner Q2-Ergebnisse; Geschäftsjahr 2025 durch geringeres Wachstum bei Spritzen beeinflusst
H1 24 Umsatzerlöse steigen währungsbereinigt um 9 % gegenüber Vorjahr auf 489 Mio. Euro; währungsbereinigte EBITDA-Marge von 27,4 %
Prognose für Umsatzwachstum für das Geschäftsjahr 20......
Themefolio
Profiler
Peergroup
© EQS Newswire
14.05.2024
1SXP
LISTED
XETR
SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from syringes
News Preview
SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from syringes
H1 24 revenues up 9% yoy at constant currencies to EUR 489m; EBITDA margin of 27.4% at constant currencies
FY 25 revenue growth projections impacted by lower demand for syringes from one customer
Mid-term outlook confirmed
Full set of Q2......
Themefolio
Profiler
Peergroup
© PR Newswire
14.05.2024
HLN
LISTED
LSE
Haleon Canada & GlobalMedic Launch Haleon Health Trailer
News Preview
MISSISSAUGA, ON, May 14, 2024 /CNW/ - Today, Haleon (Canada), a global leader in consumer health; makers of Advil, Voltaren, Centrum, Buckley's and Sensodyne; have partnered with GlobalMedic to launch the first ever Haleon Health Trailer focused on providing self-care products and services to marginalized communities. The health trailer will help...
Themefolio
Profiler
Peergroup
© EQS Newswire
14.05.2024
1SXP
LISTED
XETR
SCHOTT Pharma sieht Geschäftsjahr 2025 durch geringeres Wachstum bei Spritzen beeinflusst
News Preview
SCHOTT Pharma sieht Geschäftsjahr 2025 durch geringeres Wachstum bei Spritzen beeinflusst
Die Gesellschaft prognostiziert gegenwärtig für ihr am 1. Oktober 2024 beginnendes Geschäftsjahr 2024/2025 abweichend von der vorherrschenden Markterwartung ein Umsatzwachstum in der Bandbreite eines hohen einstelligen bis niedrigen zweistelligen Prozentsatze......
Themefolio
Profiler
Peergroup
© EQS Newswire
14.05.2024
1SXP
LISTED
XETR
SCHOTT Pharma sieht Geschäftsjahr 2025 durch geringeres Wachstum bei Spritzen beeinflusst
News Preview
SCHOTT Pharma sieht Geschäftsjahr 2025 durch geringeres Wachstum bei Spritzen beeinflusst
Die Gesellschaft prognostiziert gegenwärtig für ihr am 1. Oktober 2024 beginnendes Geschäftsjahr 2024/2025 abweichend von der vorherrschenden Markterwartung ein Umsatzwachstum in der Bandbreite eines hohen einstelligen bis niedrigen zweistelligen Prozentsatze......
Themefolio
Profiler
Peergroup
© EQS Newswire
14.05.2024
1SXP
LISTED
XETR
SCHOTT Pharma see FY 25 impacted by slower growth from syringes
News Preview
SCHOTT Pharma see FY 25 impacted by slower growth from syringes
For its fiscal year 2024/2025, beginning 1st October 2024, the company is forecasting a revenue growth in a high single-digit to a low double-digit percentage range, which deviates from the current market consensus. Due to the revenue growth that is lower than previously expected, the......
Themefolio
Profiler
Peergroup
© Globe Newswire
14.05.2024
CHEMM
LISTED
CPH
Notification of managers’ transactions
News Preview
ANNOUNCEMENT NO. 265...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.05.2024
CHEMM
LISTED
CPH
Notification of managers’ transactions
News Preview
ANNOUNCEMENT NO. 264...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.05.2024
GMAB
LISTED
CPH
Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress
News Preview
Media ReleaseCOPENHAGEN, Denmark; May 14, 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.05.2024
AUTL
LISTED
NASDAQ
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress
News Preview
Autolus Therapeutics to present three clinical data updates at the 2024 EHA Congress...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.05.2024
MURA
LISTED
NASDAQ
Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
News Preview
Mural Oncology reiterates cash runway projection into 4Q 2025, with sufficient capital to fund key clinical readouts....
Themefolio
Profiler
Peergroup
© EQS Newswire
14.05.2024
EUZ
LISTED
XETR
Eckert & Ziegler in Q1 mit deutlichem Anstieg bei Umsatz (+17%) und bereinigtem EBIT (+41%). Jahresprognose 2024 bestätigt.
News Preview
1. Quartal 2024:
Umsatz 67,6 Mio. € (VJ: 57,9 Mio. €)
EBIT vor Sondereinflüssen 15,0 Mio. € (VJ:10,6 Mio. €)
Nettogewinn 8,5 Mio. € (VJ: 4,7 Mio. €)
Jahresprognose 2024:
Umsatz von knapp 265 Mio. € (bestätigt)
EBIT vor Sondereinflüssen von rund 50 Mio. € (bestätigt)
Berlin, 14.05.2024. Die Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) ......
Themefolio
Profiler
Peergroup
© EQS Newswire
14.05.2024
EUZ
LISTED
XETR
Eckert & Ziegler in Q1 mit deutlichem Anstieg bei Umsatz (+17%) und bereinigtem EBIT (+41%). Jahresprognose 2024 bestätigt.
News Preview
1. Quartal 2024:
Umsatz 67,6 Mio. € (VJ: 57,9 Mio. €)
EBIT vor Sondereinflüssen 15,0 Mio. € (VJ:10,6 Mio. €)
Nettogewinn 8,5 Mio. € (VJ: 4,7 Mio. €)
Jahresprognose 2024:
Umsatz von knapp 265 Mio. € (bestätigt)
EBIT vor Sondereinflüssen von rund 50 Mio. € (bestätigt)
Berlin, 14.05.2024. Die Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) ......
Themefolio
Profiler
Peergroup
© EQS Newswire
14.05.2024
EUZ
LISTED
XETR
Eckert & Ziegler with significant increase in sales (+17%) and adjusted EBIT (+41%) in Q1. Forecast 2024 confirmed.
News Preview
1st Quarter 2024:
Sales of € 67.6 million (previous year: € 57.9 million)
EBIT before special items of € 15.0 million (previous year: € 10.6 million)
Net income € 8.5 million (previous year: € 4.7 million)
Forecast FY 2024:
Sales of just under € 265 Mio. (confirmed)
EBIT before special items of around € 50 million (confirmed)
Berlin, 14 May 2......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
